v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue:    
Total revenue $ 1,681 $ 1,034
Operating expenses:    
Research and development 8,717 11,799
Selling, general, and administrative 5,084 9,856
Goodwill impairment 0 20,950
Total operating expenses 13,801 42,605
Loss from operations (12,120) (41,571)
Royalty liability interest expense - related parties (9,121) (8,377)
Other interest income, net 28 119
Non-operating (expense) income, net (2) 439
Loss before income taxes (21,215) (49,390)
Income tax expense (7) (2)
Net loss (21,222) (49,392)
Net loss attributable to noncontrolling interest 0 (2,506)
Net loss attributable to Cibus, Inc. stockholders $ (21,222) $ (46,886)
Basic net loss per share of Class A common stock (in dollars per share) $ (0.33) $ (1.34)
Diluted net loss per share of Class A common stock (in dollars per share) $ (0.33) $ (1.34)
Weighted average shares of Class A common stock outstanding - basic (in shares) 65,202,244 35,052,692
Weighted average shares of Class A common stock outstanding - diluted (in shares) 65,202,244 35,052,692